A recent NIH-funded study indicates that semaglutide, a key ingredient in GLP-1 drugs like Ozempic, may extend lifespan and improve various health markers in older mice. The research suggests that semaglutide not only mimics the benefits of calorie restriction but may also influ…
A recent review published in the International Journal of Molecular Sciences examines over 126 studies on berberine, highlighting its effects on gut inflammation, the intestinal b…
Heineken's U.S. CEO, Maggie Timoney, recently addressed the company's strategy to market its non-alcoholic beer amid reports of historic lows in U.S. alcohol consumption. Timoney…
Recent research indicates that semaglutide, a medication commonly used for type 2 diabetes and weight management, may also reduce asthma attacks by nearly 40% and COPD flare-ups b…
A recent analysis reveals that prescription rates for GLP-1 weight-loss medications, such as Wegovy and Mounjaro, are significantly lower in England's most deprived areas, despite…
Ana Navarro, a political commentator and guest host on The View, revealed her weight loss journey during the show's 30th anniversary season debut. She humorously credited her sign…
A recent study indicates that semaglutide, a GLP-1 drug commonly used for weight loss, may extend lifespan and improve health markers in elderly mice, mimicking the effects of cal…
Recent studies indicate that GLP-1 obesity injections, including Ozempic and Mounjaro, may not be effective for all individuals, with some participants failing to achieve signific…
A recent review in JAMA Otolaryngology highlights the potential benefits of GLP-1 weight-loss drugs, such as tirzepatide, in reducing the severity of obesity-related sleep apnea.…
A recent review published in the International Journal of Molecular Sciences examines the effects of berberine on metabolism, revealing that its impact is more nuanced than often…
Recent research presented at the Endocrine Society’s ENDO 2026 meeting reveals that individuals taking GLP-1 weight loss medications, such as Ozempic and Wegovy, not only lost wei…
At the Socialism 2026 conference in Chicago, activist Da’Shaun L. Harrison criticized the diet industry for its policing of 'Black fat flesh,' labeling modern health standards as…
Sofia Carson has come under fire for her appearance at the LACMA Art+Film Gala, with fans expressing concern over Hollywood's extreme beauty standards. The backlash highlights a g…
Beauty companies are racing to address the newly coined term 'Ozempic face' as they develop treatments for facial volume loss linked to rapid weight loss, further complicating the…
Fitness coach Jacob Zemer outlines key strategies to help adults slow muscle loss as they age. He emphasizes the importance of strength training, adequate protein intake, and qual…
NVIDIA and Eli Lilly have both reported impressive quarterly earnings, showcasing their respective growth potential. NVIDIA's revenue surged by over 105% year-over-year, driven by…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
In a stunning twist of regulatory fate, the FDA has issued new hair-raising guidelines for users of GLP-1 drugs like Ozempic and Mounjaro, warning of a 37-68% increased risk of ha…